Use of interferon-.beta. or .gamma. to treat retinal edema
US6086869A · kind A · utility
6Cited by
2References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 24, 1998 |
| Grant date | Jul 11, 2000 |
| Priority date | — |
| Expiry date | Aug 24, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P27/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides methods for treating retinal edema, particularly cystoid macular edema, employing interferon (IFN)-.alpha., IFN-.beta., or IFN-.gamma.. The IFN may be administered locally, orally, or parenterally.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.